MEDIA

Latest News

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.

10 February 2023

Often Lasting Twice as Long as Any Other Neurotoxin on the Market, Daxxify Makes Its US Debut

20 December 2022

What You Should Know About Daxxify, the New Botox Alternative

21 October 2022

Aesthetics Company Appoints Chief Medical Officer

19 October 2022

A Growing Neuromodulator Market: Daxxify Approved

18 October 2022

Daxxify Is The New Injectable You’re Going To See Everywhere in 2023

26 September 2022

Two New Studies Highlight the Efficacy and Safety Profile of Revance’s DAXXIFY

23 September 2022

Meet Daxxify, a New Botox Alternative That Was Just Approved by the FDA

15 September 2022

What Is Daxxify, and Why Would I Want to Inject It in My Face

08 September 2022

FDA Approves Daxxify from Revance

08 September 2022

FDA Approves Daxibotulinumtoxin A for Injection for Glabellar Lines

09 July 2022

9 Ways To Treat Smile Lines

07 July 2022

The Latest News In The World of Injectable Fillers